About 500 Oceanside workers responsible for producing batches of Genentech's best-selling cancer drug Avastin will keep their jobs under a plan to merge the biotech behemoth into Swiss drug maker Roche and align the businesses' manufacturing sites worldwide, Genentech said last week...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129